G 13 7 (Oxcarbazepine 150 mg)
Pill imprint G 13 7 has been identified as Oxcarbazepine 150 mg.
Oxcarbazepine is used in the treatment of seizures; trigeminal neuralgia; cyclothymic disorder; bipolar disorder; anxiety and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Oxcarbazepine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for G 13 7 (Oxcarbazepine 150 mg)
- 150 mg
- 11.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Glenmark Generics Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|33261-0684||Aidarex Pharmacuticals LLC (repackager)|
Note: Inactive ingredients may vary.
Oxcarbazepine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...